Recent studies have identified gene expression changes triggered by KRAS mutations, and some studies have shown that KRAS mutations increase the expression of VEGFR1 and VEGFR2 in CRC and lung adenocarcinoma, but the mechanism of this association remains unclear [36, 37]. The gene discussed is KDR; the disease is lung adenocarcinoma.